SGHT
Sight Sciences, Inc. · Healthcare
Director and 10% owner Staffan Encrantz bought $498K of Sight Sciences, Inc.
Bought$497,918
$3.46Price
144,000Shares
+2%Stake
What SGHT did for a copier
- $1,000 copied at Mon, Dec 4 open, $3.05
- $1,708
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Jan 18 close.
Staffan Encrantz's record
8 other buys with 3 months of prices since 2021: on average −11.9% against the S&P 500, and 2 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Nov 29. Filed Fri, Dec 1, 7:39 PM ET, after the close. Returns use the Dec 4 open and the Jan 18 close. Not investment advice.